Dr. Lal Path Labs Ltd. (NSE:LALPATHLAB) — Stock Price

Rs1954.00 INR
▲ 1.16% today

Dr. Lal Path Labs Ltd. (NSE:LALPATHLAB) is currently trading at Rs1954.00 INR, up 1.16% today. Over the past 52 weeks, shares have ranged between Rs1307.60 and Rs3473.50. This page tracks Dr. Lal Path Labs Ltd.'s live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Dr. Lal Path Labs Ltd..

Dr. Lal Path Labs Ltd. (LALPATHLAB) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Dr. Lal Path Labs Ltd.'s daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Dr. Lal Path Labs Ltd. Income Statement — Revenue, Profit & Earnings by Year

Dr. Lal Path Labs Ltd.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs27.63 Billion Rs24.61 Billion Rs22.27 Billion Rs20.17 Billion Rs20.87 Billion
Cost of Revenue Rs16.02 Billion Rs8.23 Billion Rs7.64 Billion Rs7.29 Billion Rs5.02 Billion
Gross Profit Rs11.61 Billion Rs16.38 Billion Rs14.62 Billion Rs12.87 Billion Rs15.85 Billion
Research & Development — — Rs38.79 Million Rs36.00 Million Rs33.85 Million
SG&A — Rs3.42 Billion Rs3.13 Billion Rs2.82 Billion Rs2.85 Billion
Total Operating Expenses Rs5.40 Billion Rs10.78 Billion Rs9.95 Billion Rs9.36 Billion Rs8.48 Billion
Operating Income Rs6.21 Billion Rs5.60 Billion Rs4.67 Billion Rs3.51 Billion Rs7.37 Billion
EBITDA Rs7.83 Billion Rs7.89 Billion Rs6.78 Billion Rs5.32 Billion Rs6.13 Billion
EBIT Rs6.21 Billion Rs6.47 Billion Rs5.35 Billion Rs3.81 Billion Rs5.05 Billion
Interest Expense Rs228.00 Million Rs223.00 Million Rs293.59 Million Rs375.33 Million Rs301.71 Million
Income Before Tax Rs6.69 Billion Rs6.25 Billion Rs5.05 Billion Rs3.44 Billion Rs4.75 Billion
Income Tax Expense Rs1.59 Billion Rs1.33 Billion Rs1.43 Billion Rs1.03 Billion Rs1.25 Billion
Net Income Rs5.05 Billion Rs4.87 Billion Rs3.58 Billion Rs2.39 Billion Rs3.45 Billion

Dr. Lal Path Labs Ltd. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Dr. Lal Path Labs Ltd.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs31.46 Billion Rs27.17 Billion Rs24.56 Billion Rs23.86 Billion Rs23.53 Billion
Total Current Assets Rs15.67 Billion Rs13.63 Billion Rs11.27 Billion Rs9.73 Billion Rs8.75 Billion
Cash & Equivalents — Rs2.69 Billion Rs3.36 Billion Rs2.50 Billion Rs3.57 Billion
Short-term Investments Rs4.23 Billion Rs8.71 Billion Rs5.82 Billion Rs5.87 Billion Rs3.03 Billion
Net Receivables Rs1.12 Billion Rs1.24 Billion Rs1.10 Billion Rs722.00 Million Rs1.23 Billion
Inventory Rs439.00 Million Rs361.00 Million Rs373.07 Million Rs338.00 Million Rs525.41 Million
Property, Plant & Equipment — Rs3.39 Billion Rs3.47 Billion Rs4.04 Billion Rs4.30 Billion
Goodwill Rs5.48 Billion Rs5.48 Billion Rs5.48 Billion Rs5.48 Billion Rs5.50 Billion
Total Liabilities Rs6.05 Billion Rs5.10 Billion Rs5.71 Billion Rs6.86 Billion Rs8.10 Billion
Total Current Liabilities Rs4.51 Billion Rs4.03 Billion Rs4.65 Billion Rs4.70 Billion Rs5.00 Billion
Long-term Debt — Rs0.00 Rs0.00 Rs833.00 Million Rs1.67 Billion
Net Debt Rs-7.11 Billion Rs-6.81 Billion Rs-1.14 Billion Rs1.56 Billion Rs1.54 Billion
Total Stockholder Equity Rs25.08 Billion Rs21.73 Billion Rs18.49 Billion Rs16.66 Billion Rs15.08 Billion
Retained Earnings — Rs18.60 Billion Rs15.09 Billion Rs14.53 Billion Rs12.09 Billion

Dr. Lal Path Labs Ltd. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Dr. Lal Path Labs Ltd. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs7.02 Billion Rs5.69 Billion Rs5.35 Billion Rs4.56 Billion Rs4.47 Billion
Capital Expenditures Rs1.67 Billion Rs443.00 Million Rs511.67 Million Rs446.00 Million Rs4.76 Billion
Free Cash Flow Rs5.35 Billion Rs5.25 Billion Rs4.84 Billion Rs4.11 Billion Rs-294.49 Million
Investing Cash Flow Rs-4.88 Billion Rs-3.03 Billion Rs-242.69 Million Rs-2.87 Billion Rs-4.49 Billion
Financing Cash Flow Rs-2.63 Billion Rs-3.34 Billion Rs-4.14 Billion Rs-2.83 Billion Rs1.36 Billion
Dividends Paid Rs2.23 Billion Rs2.07 Billion Rs2.01 Billion Rs1.03 Billion Rs1.17 Billion
Stock-Based Compensation — Rs272.00 Million Rs217.06 Million Rs228.00 Million Rs323.09 Million
Depreciation Rs1.62 Billion Rs1.42 Billion Rs1.44 Billion Rs1.50 Billion Rs1.08 Billion
Change in Cash Rs6.16 Billion Rs-683.33 Million Rs972.02 Million Rs-1.15 Billion Rs1.34 Billion

Dr. Lal Path Labs Ltd. Earnings History — EPS Actual vs. Analyst Estimates

Track Dr. Lal Path Labs Ltd.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 30, 2026 8.44 8.24 +2.43%
Jan 30, 2026 6.73 6.84 -1.61%
Oct 31, 2025 9.01 9.04 -0.33%
Jul 31, 2025 7.93 7.16 +10.75%
Apr 25, 2025 9.27 5.88 +57.65%
Jan 30, 2025 5.79 5.94 -2.53%
Oct 23, 2024 7.74 7.48 +3.48%
Aug 07, 2024 6.38 5.93 +7.59%